eMDPI DS

· Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for eMDPI DS, covering 2023-03-14 to 2023-03-14. Get the full timeline:

Most recent: Clinical Trial Update: A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma [Phase 4]

See pricing